mRNA-based COVID vaccines generate improved responses to immunotherapy

Published Date: 20 Oct 2025

Patients with cancer who received mRNA-based COVID vaccines within 100 days of starting immune checkpoint therapy were twice as likely to be alive three years after beginning treatment, according to a new study led by researchers ...

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Pulled Myeloma Drug Improves Survival in Trial

2.

AZD0486 Shows Good Efficacy in Relapsed/Refractory Follicular Lymphoma

3.

OA Tied to Arthritis AE Risk in ICI-Treated Patients

4.

Admissions, medical schools, costs, and eligibility requirements information for FNB Onco-Anesthesia.

5.

Can Concurrent Boost Safely Shorten Breast Cancer Radiation?


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot